Robert Renninger
Insider Reports History
- Location
- Bothell, WA
- Signature
- /s/ Mark Worthington Attorney-in-Fact for Robert Renninger
- All insider transactions
- Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date
Holdings reported by Robert Renninger:
| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| LeonaBio, Inc. | CHIEF FINANCIAL OFFICER | Common Stock | 15,851 | $85,119 | $5.37 | 04 Mar 2026 | Direct |
| LeonaBio, Inc. | CHIEF FINANCIAL OFFICER | Restricted Stock Units | 0 | $21,914 | $0.5619 | 03 Mar 2026 | Direct |
| LeonaBio, Inc. | CHIEF FINANCIAL OFFICER | Stock Option (Right to Buy) | 300,000 | 09 Apr 2026 | Direct |
Insider Reports Filed by Robert Renninger
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| LONA | LeonaBio, Inc. | 09 Apr 2026 | 1 | $0 | 4 | CHIEF FINANCIAL OFFICER | 13 Apr 2026, 16:47 |
| LONA | LeonaBio, Inc. | 03 Mar 2026 | 3 | -$4,865 | 4 | CHIEF FINANCIAL OFFICER | 05 Mar 2026, 19:10 |
| ATHA | Athira Pharma, Inc. | 31 Dec 2025 | 4 | +$267 | 4 | Chief Financial Officer | 05 Jan 2026, 19:50 |
| ATHA | Athira Pharma, Inc. | 24 Dec 2025 | 1 | $0 | 4 | Chief Financial Officer | 29 Dec 2025, 16:19 |
| ATHA | Athira Pharma, Inc. | 30 Jun 2025 | 4 | +$1,462 | 4 | SVP, Finance and Accounting | 02 Jul 2025, 16:32 |
| ATHA | Athira Pharma, Inc. | 03 Mar 2025 | 1 | $0 | 4/A | SVP, Finance and Accounting | 12 Mar 2025, 17:20 |
| ATHA | Athira Pharma, Inc. | 31 Dec 2024 | 4 | +$389 | 4 | VP of Finance | 03 Jan 2025, 17:01 |
| ATHA | Athira Pharma, Inc. | 01 Oct 2024 | 2 | $0 | 4 | VP of Finance | 03 Oct 2024, 19:17 |
| ATHA | Athira Pharma, Inc. | 01 Oct 2024 | 0 | $0 | 3 | VP of Finance | 03 Oct 2024, 19:05 |